Default company panoramic image


A nanomaterials company initially focusing on Life Science Assay Enhancement products that boost assay sensitivity enormously.

  • Stage Full Product Ready
  • Industry Nanotechnology
  • Location Baltimore, MD, USA
  • Currency USD
  • Founded August 2009
  • Employees 4
  • Website

Company Summary

Plasmonix's is focused on Metal Enhanced Fluorescence (MEF) products for life science and clinical diagnostic applications where our technology increases assay sensitivity enormously, saving customers time and money. We introduced our first QuantaWell microplate product and expect to introduce two other configurations in the coming months. Customers are pharmaceuticals, biotechs, academic researchers, quality control, diagnostics, etc.


  • Default avatar
    William Gust
    President & CEO

    30+ years of venture capital experience nurturing and supporting start-up companies as BioRexis, Immunicon (NASDAQ: IMMC), HealthSouth Rehabilitation (NYSE: HLS), GlycoMimetics, Sensors for Medicine & Science, Apple Computer (NASDAQ: AAPL), Chucky Cheese (NYSE: CEC), and Sequoia Software (NASDAQ: SQSW). Prior to his venture capital career, Gust was with First Boston and L.F. Rothschild in security analysis and investment banking.

  • Default avatar
    Sean Higgins

    Strong background in molecular and cell biology; 10 years with Meso Scale, Covance and Luminex prior to Plasmonix. Deep experience in research & development, customer support, project management, solution-based product design, assay design and hands-on, direct interface with customer scientists.

  • Default avatar
    James Russo
    VP-Manufacturing & Process Development

    17 years in senior operating positions in life science companies such as Life Technologies, Thermo Fisher, In Vitro Technologies and Bioarray Solutions. In addition, important experience in imaging during the years he spent with Leica, where he was involved in the design and manufacturing of diagnostic systems.


  • Default avatar
    Duane Morris
    Default avatar
    Gross Mendelsohn

Previous Investors

  • Default avatar
    Maryland Healthcare Product Development Corporation
    Default avatar
    Default avatar
    Angel Investors